Cerebrospinal fluit abnormalities in a phase III trial of Avonex (IFNβ-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group. - Rudick,R.A.; Coofair,D.L.; Simonian,N. (J Neuroimmunol, 1999)